Rising Star: Vega Targets Rare Blood Disorders with Antibodies
Like its namesake star twinkling 25 light-years from Earth, ...
A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial
Biotech incubator Star Therapeutics has launched another galaxy-themed drug ...
Star Therapeutics launches Vega, growing its galaxy of drug startups
Vega Therapeutics is the second company to emerge from ...
Another star is born: Vega Therapeutics targets protein S for bleeding disorders
Vega Therapeutics Inc. emerged from stealth in advance of ...
Vega Therapeutics launches and unveils its first-in-class antibody therapy for von Willebrand disease at ASH Annual Meeting
With $40 million in financing to date, company has ...
The path to a ‘purpose-built’ antibody for an overlooked bleeding disorder
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident